BackEagle Pharmaceuticals Overview

Eagle Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for EGRX.

Quarterly EBIT

$5.17M
↑ 134.5% YoY

As of Jun 30, 2023

Annual EBIT (TTM)

$30.28M
↓ 47.57% YoY

Trailing 12 months ending Jun 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin